Upgrade to SI Premium - Free Trial

Globus Medical (GMED) PT Raised to $30 at BofA/Merrill Lynch Following Q4, Branch Deal

February 26, 2015 8:37 AM
BofA/Merrill Lynch analyst Bob Hopkins reiterated a Buy rating and boosted his price target on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles